ForgerF, MatthiasT, OppermannM, et al.Infliximab in breast milk. Lupus, 2004; 13:753.
2.
OstensenM, EigenmannGO. Etanercept in breast milk. J Rheumatol, 2004; 31:1017.
3.
MathesonI, SamsethM, LobergR, et al.Milk transfer of phenoxymethylpenicillin during puerperal mastitis. Br J Clin Pharmacol, 1988; 25:33–40.
4.
NakamuraT, HashimotoI, SawadaY, et al.[Clinical studies on cefuroxime axetil in acute mastitis] (article in Japanese). Jpn J Antibiot, 1987; 40:340–348.
5.
FritzscheJ, PilchA, MuryD, et al.Infliximab and adalimumab use during breastfeeding. J Clin Gastroenterol, 2012; 46:718–9.
6.
BakerTE, CooperSD, KesslerL, et al.Transfer of natalizumab into breast milk in a mother with multiple sclerosis. J Hum Lact, 2015; 31:233–236.
7.
RossE, RobinsonSE, AmatoC, et al.Therapeutic monoclonal antibodies in human breast milk: A case study. Melanoma Res, 2014; 24:177–180.
8.
MahadevanU, MatroR. Care of the pregnant patient with inflammatory bowel disease. Obstet Gynecol, 2015; 126: 401–412.
9.
van der WoudeCJ, ArdizzoneS, BengtsonMB, et al.The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis, 2015; 9:107–124.
10.
FlintJ, PanchalS, HurrellA, et al.BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford), 2016. doi:10.1093/rheumatology/kev404.
11.
NguyenGC, SeowCH, MaxwellC, et al.The toronto consensus statements for the management of IBD in pregnancy. Gastroenterology, 2016; 150:734–57.
